Skip to main content
Clinical Trials/NCT01940068
NCT01940068
Completed
Not Applicable

A Double-blind Randomized Controlled Trial of a Thickened Amino-acid-based Formula in Children Allergic to Cow's Milk and to Protein Hydrolysates

United Pharmaceuticals1 site in 1 country86 target enrollmentMarch 2011

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Cow Milk Allergy
Sponsor
United Pharmaceuticals
Enrollment
86
Locations
1
Primary Endpoint
Number of withdrawal for intolerance
Status
Completed
Last Updated
11 years ago

Overview

Brief Summary

The purpose of this study is to evaluate the impact of a new Amino-acid based formula on allergic symptoms and growth of infants with cow's milk protein allergy and intolerant to extensively hydrolysed formulas;

Registry
clinicaltrials.gov
Start Date
March 2011
End Date
December 2013
Last Updated
11 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • less than 18 months old
  • with a proven cow's milk protein allergy by a double blind placebo controlled food challenge or a positive Skin prick test (\>=6mm) or specific immunoglobulin E \>= 5 kilo-unit/L or combination
  • still symptomatic while fed an extensively hydrolysed formula

Exclusion Criteria

  • Exclusively breast fed infants
  • non allergic digestive enteropathy

Outcomes

Primary Outcomes

Number of withdrawal for intolerance

Time Frame: 1 month

Study Sites (1)

Loading locations...

Similar Trials